Study on effect of Baoyuan Qiangshen Tablet No. I in prolongating interval of hemodialysis in patients of renal disease in terminal stagein prolongating interval of hemodialysis in patients of renal disease in terminal stage

Zhu Bi-Jiang; Li Yu-Sheng

doi:10.1007/BF02935427

Your Location：

Home >

Browse articles >

Study on effect of Baoyuan Qiangshen Tablet No. I in prolongating interval of hemodialysis in patients of renal disease in terminal stagein prolongating interval of hemodialysis in patients of renal disease in terminal stage

OriginalPaper | Updated：2021-08-27

- Study on effect of Baoyuan Qiangshen Tablet No. I in prolongating interval of hemodialysis in patients of renal disease in terminal stagein prolongating interval of hemodialysis in patients of renal disease in terminal stage
- Study on effect of Baoyuan Qiangshen Tablet No. I in prolongating interval of hemodialysis in patients of renal disease in terminal stagein prolongating interval of hemodialysis in patients of renal disease in terminal stage
- 中国结合医学杂志（英文版） 1997年3卷第1期页码：12-16
- Affiliations：
  
  Jiangsu Research Center of Nephrology -with TCM-,Zhenjiang,Jiangsu,WM
- Author bio：
- Funds：
- DOI：10.1007/BF02935427
  中图分类号：
- 纸质出版日期：1997，
Scan for full text
Zhu, BJ., Li, YS. Study on effect of Baoyuan Qiangshen Tablet No. I in prolongating interval of hemodialysis in patients of renal disease in terminal stagein prolongating interval of hemodialysis in patients of renal disease in terminal stage., CJIM 3, 12–16 (1997). https://doi.org/10.1007/BF02935427

Zhu Bi-Jiang, Li Yu-Sheng. Study on effect of Baoyuan Qiangshen Tablet No. I in prolongating interval of hemodialysis in patients of renal disease in terminal stagein prolongating interval of hemodialysis in patients of renal disease in terminal stage[J]. Chinese Journal of Integrative Medicine, 1997,3(1):12-16.
Zhu, BJ., Li, YS. Study on effect of Baoyuan Qiangshen Tablet No. I in prolongating interval of hemodialysis in patients of renal disease in terminal stagein prolongating interval of hemodialysis in patients of renal disease in terminal stage., CJIM 3, 12–16 (1997). https://doi.org/10.1007/BF02935427 DOI：

Zhu Bi-Jiang, Li Yu-Sheng. Study on effect of Baoyuan Qiangshen Tablet No. I in prolongating interval of hemodialysis in patients of renal disease in terminal stagein prolongating interval of hemodialysis in patients of renal disease in terminal stage[J]. Chinese Journal of Integrative Medicine, 1997,3(1):12-16. DOI： 10.1007/BF02935427.

摘要

Objective: To evaluate the effect of Baoyuan Qiangshen Tablet No. I (BYQS)

a Chinese herbal medicine for reinforcing Kidney

activating circulation and eliminating evil Turbid factors

in prolongating interval of hemodialysis in patients of terminal stage of renal disease (TSRD).Methods: Twenty cases of TSRD were treated with BYQS combined with hemodialysis once every 5 days and the effect was observed and compared with control group treated with routine hemodialysis once every 3 days.Results: The increasing levels of serum creatinine

and blood urea nitrogen of BYQS group at dialysis interval were all lower than those of the control group (P < 0.01). After 3 months’ treatment

serum creatinine

blood urea nitrogen of BYQS group were lower than those before treatment

plasma albumin

lipoprotein

urine level of prostaglandin and anemia were all improved to various extent

but the creatinine clearance rate was unchanged. Conclusions: BYQS could prolong the interval and reduce the times of dialysis by way of regulating the lipid metabolic disorder

improving pathological change of kidney and protecting function of residual kidney unit. BYQS combined with hemodialysis is a good way of integrated traditional Chinese and Western medicine in treating TSRD.

Abstract

Objective: To evaluate the effect of Baoyuan Qiangshen Tablet No. I (BYQS)

a Chinese herbal medicine for reinforcing Kidney

activating circulation and eliminating evil Turbid factors

and blood urea nitrogen of BYQS group at dialysis interval were all lower than those of the control group (P < 0.01). After 3 months’ treatment

serum creatinine

blood urea nitrogen of BYQS group were lower than those before treatment

plasma albumin

lipoprotein

urine level of prostaglandin and anemia were all improved to various extent

but the creatinine clearance rate was unchanged. Conclusions: BYQS could prolong the interval and reduce the times of dialysis by way of regulating the lipid metabolic disorder

关键词

terminal stage of renal diseaseBaoyuan Qiangshen tablet No. Ihemodialysis

Keywords

terminal stage of renal diseaseBaoyuan Qiangshen tablet No. Ihemodialysis

references

1993; 32(2): 131–134.

1995; 4(1): 76–87.

1993; 2(3): 239–241.

1992;12(5): 285–287.

FULL TEXT LINK

More>

浏览量

378

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Clinical study on effect of chinese herbal medicine combined with hemodialysis in treating uremia

Changes of QT Dispersion in Hemodialysis Patients after Administrating Zhigancao Decoction (炙甘草汤)